1. ALLA AKTIER
  2. NYHETER
  3. MAGLE CHEMOSWED

Magle Chemoswed

Nyheter Magle Chemoswed Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Announcement of CFO Petra Jönsson Sjölin’s Resignation

MAR

Magle Group announces that Petra Jönsson Sjölin has decided to step down from her position as Chief Financial Officer (CFO).

Petra has played a pivotal role in shaping Magle Group’s financial strategy, overseeing key initiatives, and contributing to the Group’s ongoing success.

“We extend our heartfelt gratitude to Petra for her significant contributions to Magle Group during her tenure. Her expertise and leadership have been instrumental in our growth and transformation,” said Hans Henrik Lidgard, Chair of Magle Group.

The Board and management team wish Petra the very best in her future endeavours.

Magle Group has commenced the transition process and will announce Petra’s successor in the near future.

Contacts

Justin Pierce, CEO, phone +46 (0)70 593 58 21, justin.pierce@maglechemoswed.com

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes three operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Magle Biopolymers A/S- a specialized manufacturing organization of Dextran technology. Learn more on www.maglechemoswed.com and www.maglegroup.com and www.maglepharmacept.com and www.maglebiopolymers.com

Vator Securities is the Company's certified adviser on Nasdaq First North Growth Market and can be reached at ca@vatorsec.se or +46 (0)8-580 065 99.

This information is information that Magle Chemoswed is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-12-05 08:50 CET.

Attachments

Announcement of CFO Petra Jönsson Sjölin’s Resignation

Datum 2024-12-05, kl 08:50
Källa MFN
Bifogade filer
Announcement of CFO Petra Jönsson Sjölin’s Resignation